Cited in boardrooms, legal proceedings & government briefings since 2017
Medical cannabis sales and registered patients in Greece, 2025 actuals and the 2027 forecast. Forecasts to 2030 are in the Greece data pack.
Medical sales, EUR
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| Medical sales | €27.4m | €40m | €49.2m | |||
| Patients | 22,117 | 32,320 | 39,697 |
Forecasts to 2030 — sales, patients and the full Greece series — are in the Greece data pack, or scoped to your question in a bespoke brief.
See the data pack Request a briefSource: Prohibition Partners — Global Medical Cannabis Market Review (2026, updated April 2026) & The European Cannabis Report (2025)
How Greece’s framework got here, and what moves next.
Medical cannabis legalised
Greece reschedules cannabis from Schedule A to D following a campaign led by the patient advocacy group MAMAKA.
Cultivation legalised
Law 4523/2018 legalises medical cannabis cultivation and processing, positioning Greece as a production hub.
Import ban prioritises domestic supply
Article 71 of Law 4864/2021 bans medical cannabis imports, tying the market's fortunes to domestic cultivation.
First products reach patients
The first medical cannabis products become available in Greece on 19 February 2024 — seven years after legalisation.
Market build-out from a late start
Sales growth from the February 2024 launch is tracked against PP's forecast in Market Intelligence.
From International Cannabis Weekly, our free global briefing.
Newsweed · №450 · 22 May 2026 · Regulation
Business of Cannabis · №449 · 15 May 2026 · Regulation
№356 · 5 Jul 2024 · Business & Investment
№353 · 14 Jun 2024 · Medical
№346 · 26 Apr 2024 · Medical
№344 · 12 Apr 2024 · Events & Industry
The first medical cannabis products were made available in Greece on 19 February 2024, which has brought forth a much-anticipated turning point for the growth of the country’s medical cannabis market, as well as providing relief for many patients and advocates. Greece’s estimated medical market size for 2025 is over €13 million.
Although Greece was one of the first countries to legalise medical cannabis in Europe, it took almost seven years for patients to receive medical cannabis treatment. The prolonged delay was due to political changes and a long process in establishing regulatory frameworks for medical cannabis prescription and dispensation, cultivation and production, and the product approval process.
Today, the market is driven by Tikun Olam, which has established itself as the first medical cannabis producer in Greece and has the only products approved on the market. The company currently holds three different flower strains on the market and plans to expand its flower portfolio and introduce its extract products.
Medical cannabis imports remain banned in Greece, however, Tikun Olam exported its first medical cannabis products to Switzerland in November 2024, with the company aiming to supply other markets. In Q1 2025, Greece exported 49 kilograms of medical cannabis to Germany. Additionally, Greece is ramping up its domestic production as more companies are receiving licences to operate, with Curity Pharma receiving its operational cultivation licence in March 2025.
In the full Greece market data
Sizing, forecasts, pricing, trade flows and licensed operators — verified by PP’s analysts. Available as a data pack.